159 related articles for article (PubMed ID: 24395571)
1. Kisspeptin effect on endothelial monocyte activating polypeptide II (EMAP-II)-associated lymphocyte cell death and metastases in colorectal cancer patients.
Stathaki M; Armakolas A; Dimakakos A; Kaklamanis L; Vlachos I; Konstantoulakis MM; Zografos G; Koutsilieris M
Mol Med; 2014 Mar; 20(1):80-92. PubMed ID: 24395571
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism.
Murray JC; Symonds P; Ward W; Huggins M; Tiga A; Rice K; Heng YM; Todd I; Robins RA
J Immunol; 2004 Jan; 172(1):274-81. PubMed ID: 14688335
[TBL] [Abstract][Full Text] [Related]
3. Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis.
Murray JC; Heng YM; Symonds P; Rice K; Ward W; Huggins M; Todd I; Robins RA
J Leukoc Biol; 2004 May; 75(5):772-6. PubMed ID: 14982944
[TBL] [Abstract][Full Text] [Related]
4. Serum endothelial monocyte-activating polypeptide-II: a novel biomarker in patients with non-small-cell lung cancer.
Sen E; Ulger F; Kaya A; Akar N; Gonullu U
Clin Lung Cancer; 2008 May; 9(3):166-70. PubMed ID: 18621627
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).
Berger AC; Alexander HR; Wu PC; Tang G; Gnant MF; Mixon A; Turner ES; Libutti SK
Cytokine; 2000 Jul; 12(7):992-1000. PubMed ID: 10880244
[TBL] [Abstract][Full Text] [Related]
6. Cell-surface associated p43/endothelial-monocyte-activating-polypeptide-II in hepatocellular carcinoma cells induces apoptosis in T-lymphocytes.
Faisal W; Symonds P; Panjwani S; Heng Y; Murray JC
Asian J Surg; 2007 Jan; 30(1):13-22. PubMed ID: 17337366
[TBL] [Abstract][Full Text] [Related]
7. EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer.
Youssef MM; Symonds P; Ellis IO; Murray JC
Br J Cancer; 2006 Sep; 95(6):735-43. PubMed ID: 16929248
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced EMAP-II transcription in colorectal cancer.
Youssef MM; Heng YM; Powe DG; Edgson J; Ellis IO; Murray C
Egypt J Immunol; 2010; 17(2):121-9. PubMed ID: 23082492
[TBL] [Abstract][Full Text] [Related]
9. Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells.
Schwarz MA; Kandel J; Brett J; Li J; Hayward J; Schwarz RE; Chappey O; Wautier JL; Chabot J; Lo Gerfo P; Stern D
J Exp Med; 1999 Aug; 190(3):341-54. PubMed ID: 10430623
[TBL] [Abstract][Full Text] [Related]
10. Endothelial monocyte-activating polypeptide-2 is increased in pregnancy but is not further increased in preeclampsia.
Wellings RP; Lash GE; Murray JC; Tas M; Ward W; Trew AJ; Baker PN
J Soc Gynecol Investig; 1999; 6(3):142-6. PubMed ID: 10376270
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation.
Chang SY; Park SG; Kim S; Kang CY
J Biol Chem; 2002 Mar; 277(10):8388-94. PubMed ID: 11741979
[TBL] [Abstract][Full Text] [Related]
12. Endothelial-monocyte-activating polypeptide II induces rat C6 glioma cell apoptosis via the mitochondrial pathway.
Liu LB; Xie H; Xue YX; Liu YH; Li Z; Wang P
Biochem Biophys Res Commun; 2015 Feb; 457(4):595-601. PubMed ID: 25600803
[TBL] [Abstract][Full Text] [Related]
13. Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
Li Z; Liu YH; Xue YX; Liu LB; Wang P
J Mol Neurosci; 2012 Sep; 48(1):291-301. PubMed ID: 22531886
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Induces Blood-Tumor Barrier Opening Via the cAMP/PKA/Rac1 Pathway.
Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
J Mol Neurosci; 2016 Feb; 58(2):153-61. PubMed ID: 26358039
[TBL] [Abstract][Full Text] [Related]
15. Intratumoural expression of TNF-R1 and EMAP-II in relation to response of patients treated with TNF-based isolated limb perfusion.
van Horssen R; Rens JA; Brunstein F; Guns V; van Gils M; Hagen TL; Eggermont AM
Int J Cancer; 2006 Sep; 119(6):1481-90. PubMed ID: 16615114
[TBL] [Abstract][Full Text] [Related]
16. EMAP-II expression is associated with macrophage accumulation in primary uveal melanoma.
Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1801-6. PubMed ID: 12714608
[TBL] [Abstract][Full Text] [Related]
17. Endothelial monocyte activating polypeptide II in children and adolescents with type 1 diabetes mellitus: Relation to micro-vascular complications.
Adly AAM; Ismail EA; Tawfik LM; Ebeid FSE; Hassan AAS
Cytokine; 2015 Dec; 76(2):156-162. PubMed ID: 26142824
[TBL] [Abstract][Full Text] [Related]
18. Improved antitumor response to isolated limb perfusion with tumor necrosis factor after upregulation of endothelial monocyte-activating polypeptide II in soft tissue sarcoma.
Lans TE; ten Hagen TL; van Horssen R; Wu PC; van Tiel ST; Libutti SK; Alexander HR; Eggermont AM
Ann Surg Oncol; 2002 Oct; 9(8):812-9. PubMed ID: 12374666
[TBL] [Abstract][Full Text] [Related]
19. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis.
Knies UE; Behrensdorf HA; Mitchell CA; Deutsch U; Risau W; Drexler HC; Clauss M
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12322-7. PubMed ID: 9770485
[TBL] [Abstract][Full Text] [Related]
20. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.
Berger AC; Alexander HR; Tang G; Wu PS; Hewitt SM; Turner E; Kruger E; Figg WD; Grove A; Kohn E; Stern D; Libutti SK
Microvasc Res; 2000 Jul; 60(1):70-80. PubMed ID: 10873516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
